These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 33068292

  • 1. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM, Rossing K, Ihlemann N, Boesgaard S, Engstrøm T, Gustafsson F.
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F, De Luca L, Petrolini A, Di Vito L, Ghini AS, Corvo P, De Persio G, Parisi F, Pongiglione G, Giulia Gagliardi M, Prati F.
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA, Gamboa P, Renedo MF, Lev GA, Favaloro LE, Bertolotti AM.
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [Abstract] [Full Text] [Related]

  • 6. Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
    Nelson LM, Andreassen AK, Arora S, Andersson B, Gude E, Eiskjaer H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F.
    Transpl Int; 2020 May; 33(5):517-528. PubMed ID: 31958178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Coronary computed tomography in heart transplant patients: detection of significant stenosis and cardiac allograft vasculopathy, image quality, and radiation dose.
    Günther A, Aaberge L, Abildgaard A, Ragnarsson A, Edvardsen T, Jakobsen J, Andersen R.
    Acta Radiol; 2018 Sep; 59(9):1066-1073. PubMed ID: 29260577
    [Abstract] [Full Text] [Related]

  • 10. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant.
    Shah H, Lee I, Rao S, Suddath W, Rodrigo M, Mohammed S, Molina E, García-Garcia HM, Kenigsberg BB.
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):451-458. PubMed ID: 38117378
    [Abstract] [Full Text] [Related]

  • 11. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S, Chong AY, Džavík V, So DY, Aleksova N, Wells GA, Bernick J, Overgaard CB, Stadnick E, Mielniczuk LM, Beanlands RSB, Ross HJ.
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of cardiac allograft vasculopathy on dual source computed tomography in heart transplant recipients: comparison with invasive coronary angiography.
    Ojha V, Ganga KP, Mani A, Jagia P, Gulati G, Seth S, Nakra T, Arava S, Kumar S, Ray R, Sharma S.
    Br J Radiol; 2022 Jun 01; 95(1134):20211237. PubMed ID: 35230144
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound.
    Moayedi Y, Fan CPS, Tremblay-Gravel M, Miller RJH, Kawana M, Henricksen E, Parizo J, Wainwright R, Fearon WF, Ross HJ, Khush KK, Teuteberg JJ.
    Clin Transplant; 2020 Nov 01; 34(11):e14098. PubMed ID: 32970884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B, Sandri M, Luecke C, Garbade J, Gohmann R, Hahn J, Fischer J, Gutberlet M, Lehmkuhl L.
    Eur Radiol; 2020 Aug 01; 30(8):4317-4326. PubMed ID: 32179995
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stress echocardiography for assessment of cardiac allograft vasculopathy.
    Spes CH, Angermann CE.
    Z Kardiol; 2000 Aug 01; 89 Suppl 9():IX/50-3. PubMed ID: 11151793
    [Abstract] [Full Text] [Related]

  • 19. Suppressive effects of conversion from mycophenolate mofetil to everolimus for the development of cardiac allograft vasculopathy in maintenance of heart transplant recipients.
    Watanabe T, Seguchi O, Nishimura K, Fujita T, Murata Y, Yanase M, Sato T, Sunami H, Nakajima S, Hisamatsu E, Sato T, Kuroda K, Hieda M, Wada K, Hata H, Ishibashi-Ueda H, Miyamoto Y, Fukushima N, Kobayashi J, Nakatani T.
    Int J Cardiol; 2016 Jan 15; 203():307-14. PubMed ID: 26523360
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.